Search results
Showing 61 to 75 of 298 results for alcohol
parents and carers as part of a whole-school approach to promote and support alcohol education? Any explanatory notes(if applicable) Why...
Question What is the clinical and cost effectiveness of chlorhexidine in alcohol at different concentrations in the prevention of...
Recommendation ID NG135/5 Question How effective are education-based alcohol prevention interventions (universal or targeted) for...
For which service users who are moderately and severely dependent on alcohol is an assertive community treatment model a clinically and...
This guideline covers how donor milk banks should recruit, screen and support women who donate breast milk. It also covers how milk banks should handle and process the breast milk they receive from donors. It aims to improve the safety of donor milk and operation of donor milk services.
This guideline covers how to improve services for people aged 14 and above who have been diagnosed as having coexisting severe mental illness and substance misuse. The aim is to provide a range of coordinated services that address people’s wider health and social care needs, as well as other issues such as employment and housing.
Familial hypercholesterolaemia: identification and management (CG71)
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.
Recommendation ID NG135/1 Question What components of alcohol education delivery contribute to its effectiveness for children and young
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)
This guideline covers identifying and assessing risk of cardiovascular disease (CVD) in adults without established CVD. It covers lifestyle changes and lipid-lowering treatment (including statins) for primary and secondary prevention of CVD, and includes guidance for people who also have diabetes or chronic kidney disease.
Psychosis and schizophrenia in adults: prevention and management (CG178)
This guideline covers recognising and managing psychosis and schizophrenia in adults. It aims to improve care through early recognition and treatment, and by focusing on long-term recovery. It also recommends checking for coexisting health problems and providing support for family members and carers.
In development Reference number: GID-HTG10527 Expected publication date: TBC
Renal sympathetic denervation for resistant hypertension: draft scope consultation
We are listening to your views on this HealthTech guidance. Comments close 29 June 2026.
Evidence-based recommendations on interferon alfa (Pegasys or ViraferonPeg) and ribavirin for people with chronic hepatitis C.
ID CG115/5 Question For people with moderate and severe alcohol dependence who have significant comorbid problems, is an intensive...
clinical and cost effectiveness of 2% chlorhexidine in alcohol versus 0.5% chlorhexidine in alcohol versus 2% chlorhexidine...